Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Virtual reality exposure therapy (VRET) is a clinical intervention that uses immersive virtual reality technology to simulate real-life situations or feared stimuli as part of psychotherapeutic exposure and cognitive-behavioral therapy. It allows for controlled, repeatable, and individually tailored exposure, facilitating systematic desensitization or processing of trauma, anxiety, or phobic triggers. VRET is *not* a molecular target or druggable receptor—rather, it is a therapeutic method employed by mental health professionals, often as an alternative or complement to in vivo exposure therapy. The technique is primarily used for anxiety disorders, PTSD, phobias, OCD, and addiction, and is shown to be effective in reducing symptoms in these populations. Safety concerns include VR-induced discomfort ("cybersickness") and the need for clinical supervision.
Facilitates gradual exposure to anxiety-provoking or traumatic stimuli in a controlled virtual environment, enabling desensitization and behavioral adaptation\nEngages psychological mechanisms of exposure therapy and cognitive restructuring
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Virtual reality exposure therapy (VRET).